Sam Cohen: key facts
- Kind of voice
- Sector leader
- Role
- Ph.D., Co-Founder and CEO of Ride Therapeutics
- Quoted on
- Rare diseases
- Tracked press citations
- 3
- Most recently quoted
- 29 Sept 2026
- First quoted
- 21 Sept 2026
“The promise of genetic medicines has never been greater but can only be realized by solving the delivery challenge. Ride has built a unique platform that learns the rules of delivery by measuring it directly in the body, not in a dish or a simulation.”
What Sam Cohen has said
“The promise of genetic medicines has never been greater but can only be realized by solving the delivery challenge”
co-founder and CEO of Ride · Rare diseases · 29 Sept 2026 · Ride to get up to $7.3M from CF Foundation for gene delivery tech ↗
“The promise of genetic medicines has never been greater but can only be realized by solving the delivery challenge.”
Ph.D., Co-Founder and CEO of Ride Therapeutics · Rare diseases · 21 Sept 2026 · Ride Therapeutics Secures Up To $7.3 Million From Cystic Fibrosis Foundation For AI-Designed Genetic Medicine Delivery ↗
Where Sam Cohen has been quoted
- Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicinessynbiobeta.com · 29 Sept 2026
- Ride to get up to $7.3M from CF Foundation for gene delivery techcysticfibrosisnewstoday.com · 29 Sept 2026
- Ride Therapeutics Secures Up To $7.3 Million From Cystic Fibrosis Foundation For AI-Designed Genetic Medicine Deliverypulse2.com · 21 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.